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S U M M A R Y
Background: Clinical manifestations of deep venous thrombosis (DVT) tend to overlap with those of
deep-seated musculoskeletal infections (MSIs). Consequently, the incidence of DVT as a complication of
MSI may be underestimated. The objective of this study was to evaluate the incidence, clinical features,
and outcomes of MSI-related DVT in children.
Methods: We systematically reviewed relevant studies retrieved from PubMed and Scopus databases.
Results: Overall, 93 children with MSIs who developed DVT were identiﬁed from 28 retrospective studies.
The majority were boys. Osteomyelitis was the most frequent MSI (69/74, 93%). Staphylococcus aureus was
the predominant pathogen (83/93, 89%); 61% of these isolates were methicillin-resistant S. aureus (MRSA).
Pulmonary involvement, presumably due to septic emboli, was observed in 65% of the included children.
Four children died due to multiple organ failure and two due to respiratory distress. In two of the three
studies providing comparative data, MRSA infections were observed signiﬁcantly more frequently in
children who developed DVT compared to those who did not. Yet, the respective differences observed for
methicillin-susceptible S. aureus (MSSA) infections were non-signiﬁcant in these three studies.
Conclusions: Despite the inclusion of many case reports and the retrospective design of the evaluated
studies, our ﬁndings suggest that boys seem to be more frequently affected by MSIs complicated by DVT.
Moreover, MRSA seems to be more frequently associated with DVT compared to MSSA. Pulmonary
involvement appears to be a frequent complication. Prospective studies are needed in order to further
clarify this issue.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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It has been recognized since the time of Virchow that venous
thromboembolism (VTE) is the result of a hypercoagulable state in
association with vessel wall dysfunction.1 These two factors
combined with hemodynamic changes, such as blood stasis due to
prolonged immobilization, can lead to reduced blood ﬂow and
eventually clot formation.1 It is further known that inﬂammation
leads to a pro-coagulant state by various mechanisms, including
promotion of leukocytes’ adhesion to endothelial cells by cytokine-
mediated down-regulation of thrombomodulin and of endothelial
cell protein C receptor, which results in a reduction of the
generation of the natural anticoagulant, activated protein C.2
In patients with musculoskeletal infections (MSIs), especially
osteomyelitis of the long bones, bed rest, along with the presence* Corresponding author. Tel.: +30 210 6839604; fax: +30 210 6839605.
E-mail address: m.falagas@aibs.gr (M.E. Falagas).
1201-9712/$36.00 – see front matter  2012 International Society for Infectious Disea
doi:10.1016/j.ijid.2011.12.012of a difﬁcult-to-treat infection create an ideal background for the
development of deep venous thrombosis (DVT). The association of
deep-seated MSIs, such as osteomyelitis, pyomyositis, and septic
arthritis, with DVT has been recognized for decades. However,
since DVT of the extremities usually presents with localized pain
and edema, which are similar to the symptoms and signs of a MSI,
many physicians may not proceed with appropriate imaging
studies in order to exclude a diagnosis of co-existing DVT.
Therefore, the incidence of DVT as a complication of MSIs may
be underestimated.
We aimed to perform a systematic review of the literature in
order to evaluate the frequency of DVT in pediatric patients with
MSIs, as well as the associated non-orthopedic complications that
result from dissemination of the infection. Additionally, since
Staphylococcus aureus is the most common pathogen responsible
for MSIs, we sought to evaluate the available evidence regarding
the prevalence of methicillin-susceptible S. aureus (MSSA) versus
methicillin-resistant S. aureus (MRSA) isolates in cases of MSI
complicated by DVT. Finally, we sought to investigate potentialses. Published by Elsevier Ltd. All rights reserved.
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clinical parameters, including length of hospital stay, in children
with MSIs with or without DVT.
2. Methods
2.1. Data sources
The studies included in this review were retrieved from
literature searches of the PubMed and Scopus databases during
January 2011. The search strategy applied on both databases was
‘‘(osteomyelitis OR musculoskeletal infection) AND (venous
thrombosis OR thrombophlebitis)’’. The bibliographies of relevant
articles were also hand-searched.Potentially relevant articles 
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Figure 1. Flow diagram of the detailed process for the2.2. Study selection criteria
A study was considered eligible for inclusion in this review if it
provided data on children with MSIs who developed DVT. The
presence of DVT should have been conﬁrmed by appropriate
imaging studies, such as Doppler ultrasonography, cross-sectional
imaging by computed tomography (CT) or magnetic resonance
imaging (MRI), and/or venography. Although it is more likely for a
case report to be written and/or published when it describes an
MSI complicated by DVT than if not, we did not exclude case
reports, since our goal was to summarize all of the available
literature on this subject. Studies reporting on patients with a
clinically suspected but unconﬁrmed DVT (no imaging studies
performed) during the course of an MSI were regarded as ineligible.evant articles 
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English, Spanish, French, German, Italian, or Greek were excluded.
2.3. Data extraction
Data extracted from each of the eligible studies included type of
study design, number, age, and sex of the enrolled children, clinical
and microbiological characteristics of MSIs (type, location, and
causative pathogen), and imaging methods of DVT diagnosis, as
well as non-orthopedic complications caused by the dissemination
of infection. For the included studies that provided comparative
data between children with MSIs who developed DVT and those
who did not, additional data were extracted. These referred to the
demographic characteristics (number, sex, and age), values of
inﬂammatory markers on admission (C-reactive protein (CRP) and
erythrocyte sedimentation rate (ESR)), number of MRSA/MSSA
infections, and length of hospital stay, for patients with MSIs who
developed DVT or not. Three authors (EP, EKV, and LM)
independently performed the data extraction from the eligible
articles. Disagreements were resolved by consensus in meetings
that involved all authors.
2.4. Data analysis
For comparisons regarding categorical variables, we used the
Chi-square or Fisher’s exact tests, as appropriate. A p-value of
<0.05 was used to denote statistical signiﬁcance. All comparisons
were performed with the OpenEpi software.3
3. Results
3.1. Study selection process
Figure 1 presents a ﬂow diagram of the detailed selection
process of articles for inclusion in this review. Our searches
performed in PubMed and Scopus databases generated a total of
185 and 87 articles, respectively. Twenty of these studies fulﬁlled
all our inclusion criteria. Eight additional studies qualifying for
inclusion were identiﬁed during hand-searching of the bibliogra-
phies of eligible studies. Thus, a total of 28 individual studies were
regarded as eligible for inclusion in this review.4–31
3.2. Characteristics of the included studies
Seventeen of the 28 included studies were case reports.6,7,10,13,
15–20,22–25,27,30,31 The remaining 11 were case series/cohort studies,
seven of which had a retrospective design,5,8,9,14,21,26,29 and four a
prospective design.4,11,12,28 In addition, three of the 28 included
studies provided comparative data regarding patients with MSIs
who developed DVT and patients who did not.4,8,14
3.3. Characteristics of the included pediatric patients
The main characteristics of the included patients are presented
in Table 1. A total of 93 children with MSIs who developed DVT
were included. Data regarding age were provided for 32 of the 93
children. Twenty of these 32 children (63%) were aged >6 years.
Data regarding sex were available for 67 of the 93 patients. Forty-
nine (73%) of these children were male. In addition, even though
the majority of the included children were not tested for such
disorders, six children were identiﬁed as having congenital
thrombophilic disorders. These included protein C deﬁciency
(two children), factor V Leiden heterozygous mutation (three
children), and prothrombin 20210A heterozygous mutation (one
child).3.4. Characteristics of MSIs
Data regarding the type and location of MSIs were available for
74 (80%) of the 93 evaluated patients. Osteomyelitis was the most
frequently observed type of MSI (69/74, 93%). The remaining ﬁve
patients had pyomyositis (n = 4), or septic arthritis (n = 1). The
femur was the most frequent location of osteomyelitis (involved in
31 children), followed by the tibia (18 children). S. aureus was
isolated from the majority of the included patients (83/93, 89%). In
51 (61%) of these patients, the isolated S. aureus strains were MRSA.
In 47 (92%) of these patients, the MRSA infection was community-
acquired (CA-MRSA). In 16 (19%) of the 83 children, the S. aureus
was found to be methicillin-susceptible (MSSA). In the remaining
16 patients, no data were provided regarding the antibiotic
susceptibilities of the isolated S. aureus. Among the 93 children
evaluated, 15 had a history of preceding trauma. Additionally,
among the 13 children with available data on sex and with a
history of preceding trauma, nine (69%) were boys.
3.5. Complications
Detailed data regarding the non-orthopedic complications
caused by dissemination of the infection are presented in Table
1. Pulmonary involvement was observed in 60 (65%) of the 93
children. Endocarditis was observed in three patients. Four
children died due to multiple organ failure and two due to
respiratory distress.
3.6. Comparative data regarding patients with MSIs with and without
DVT
In Table 2, we present comparative data provided by three of
the 28 included studies, regarding children with MSIs with and
without DVT.4,8,14 Speciﬁcally, among a total of 317 children with
MSIs included in these three studies, 28 (9%) developed DVT. In all
three studies, boys constituted a higher percentage among patients
who developed DVT compared to those who did not; however, the
observed differences were non-signiﬁcant. Moreover, no difference
was observed regarding the age distribution between the
compared patient groups in the three evaluated studies. In
addition, one of these studies reported signiﬁcantly higher CRP
and ESR values on admission for patients who eventually
developed DVT in comparison to those who did not.4
In two of the three evaluated studies, MRSA infection was
observed signiﬁcantly more frequently in patients who developed
DVT compared to those who did not.4,14 In the remaining study,
MRSA infection was also observed more frequently in patients with
associated DVT,8 however the observed difference was non-
signiﬁcant. Regarding MSSA infections, no difference was observed
between the compared patient groups in any of the three
studies.4,8,14 Finally, one of the three evaluated studies reported
a longer hospital stay for patients who developed DVT compared to
those who did not.8
4. Discussion
According to our ﬁndings, the majority of the evaluated
children with DVT had osteomyelitis, particularly of the long
bones (femur, tibia). Boys were encountered more frequently than
girls among the evaluated children with MSIs who developed DVT.
S. aureus was the predominant pathogen. Most of the identiﬁed S.
aureus pathogens were MRSA, and the majority of them were
community-acquired. Additionally, based on the ﬁndings of two of
the three evaluated studies that provided comparative data, MRSA
infections were observed signiﬁcantly more frequently in children
who developed DVT compared to those who did not. Of note, this
Table 1
Data extracted from the included studies evaluating patients with musculoskeletal infections who developed deep venous thrombosis
First author, publication
year [Ref.]
Study design Number of
patients
Age Sex MSI type and location Method of DVT diagnosis Causative pathogen Non-orthopedic
complications
Bouchoucha
et al., 2010 [4]
Prospective
cohort study
7 8.1 ya 6 M; 1 F 3/7 OM of the femur; 4/7 OM of the tibia Doppler US 4/7 CA-MSSA;
3/7 CA-MRSA
3/7 Pulmonary involvement;
1/7 death due to respiratory
distress
Kefala-Agoropoulou
et al., 2010 [17]
Case report 1 10 y F Pyomyositis and OM of the femur MRI CA-MRSA PVL-pos Pulmonary involvement,
encephalopathy
McDonald and
Copley 2010 [22]
Case report 1 5 y M Pyomyositis and OM of the humerus Doppler US CA-MRSA Pulmonary involvement
Bukhari and
Al-Otaibi 2009 [5]
Retrospective
case series
1 18 m F OM of the tibia Doppler US CA-MRSA None
Contreras et al., 2009 [7] Case report 1 19 m M OM of the femur MRI CA-MRSA Empyema necessitans and
pulmonary involvement
Cunnington et al., 2009 [9] Retrospective
case series
1 3 y F Septic arthritis of hip NR CA-MSSA, PVL-pos Death
Kuhfahl et al., 2009 [18] Case report 1 10 y M OM of the scapula CT CA-MRSA Pleural and pulmonary
involvement, septic shock
Tavil et al., 2009 [28] Prospective
case series
1b 12 y M Septic arthritis and OM of the femur Doppler US, CT, MRI NR Pulmonary involvement
Vander Have
et al., 2009 [29]
Retrospective
cohort study
8 NR NR NR Doppler US CA-MRSA 7/8 Pulmonary involvement
Gite et al., 2008 [10] Case report 3 13 y; 8.5 y;
6 y
NR OM of the femur Doppler US 1/3 Staphylococcus
aureus; 1/3
Enterococcus spp;
1/3 not isolated
3/3 Pulmonary involvement;
1/3 death due to respiratory
distress
LePage et al., 2008 [19] Case report 2 13 y; 15 y 2/2 M 1/2 OM of the humerus; 1/2 OM of the femur 1/2 Doppler US;
1/2 CT, MRI
1/2 MSSA; 1/2
Fusobacterium necrophorum
2/2 Pulmonary involvement
Saavedra-Lozano
et al., 2008 [26]
Retrospective
cohort study
6 NR NR NR NR 4/6 MRSA; 2/6 MSSA NR
Cherian 2008 [6] Case report 1 10 y M Initially: OM of the left tibia; 6 days after
hospitalization: multifocal OM of the right femur
and septic arthritis of the right knee joint
Doppler US, venogram CA-MRSA ICU admission for follow-up
Hollmig et al., 2007 [14] Retrospective
cohort study
11c 10.9 ya 8/11 M;
3/11 F
4/11 OM of the tibia; 4/11 OM of the femur;
1/11 OM of the ﬁbula; 1/11 OM of the sacrum;
1/11 OM of the thoracic spine
4/11 Doppler US;
3/11 CT; 3/11 MRI;
1/11 echocardiogram
8/11 CA-MRSA;
3/11 CA-MSSA
7/11 Pulmonary involvement;
1/11 bacterial endocarditis
Nourse et al., 2007 [24] Case report 4 17 m; 13 y;
4.5 y; 12 y
2/4 M;
2/4 F
1/4 OM of the femur; 1/4 OM of the hip, ankle;
2/4 pyomyositis of the lower limb muscles
4/4 Doppler US 3/4 CA-MRSA, PVL-pos;
1/4 CA-MRSA
4/4 Pulmonary involvement;
2/4 pleural involvement
Petrocheilou et al., 2007 [25] Case report 1 16 y M Pyomyositis of the lower limb muscles Doppler US Staphylococcus aureus Pulmonary involvement and
septic shock
Crary et al., 2006 [8] Retrospective
cohort study
10d 10.8 ya 7/10 M;
3/10 F
3/10 OM of the femur; 3/10 OM of the tibia;
2/10 OM of the femur, ﬁbula; 1/10 OM of the
sacrum; 1/10 OM of the thoracic vertebrae
3/10 MRI; 2/10 CT; 2/10
Doppler US; 2/10
echocardiogram;
1/10 venogram
7/10 CA-MRSA; 2/10
CA-MSSA;
1/10 Candida tropicalis
6/10 Pulmonary involvement;
1/10 cerebral microabscesses;
1/10 endocarditis
Gonzalez et al., 2006 [12] Prospective
cohort studye
9f 10.6 ya 9/9 M 3/9 OM of the femur; 2/9 OM of the tibia;
2/9 OM of the femur, tibia; 1/9 OM of the ileum;
1/9 OM of the ileum, ischium, pubis
3/9 Doppler US or CT;
6/9 MRI
7/9 CA-MRSA, PVL-pos;
2/9 CA-MSSA
5/9 Pulmonary involvement;
1/9 pleural involvement
Gonzalez et al., 2005 [11] Prospective
cohort study
4g NR NR 4/4 OM adjacent to DVT NR NR 2/4 Pulmonary involvement
Martinez-Aguilar
et al., 2004 [21]
Retrospective
cohort study
5 NR NR NR Doppler US 4/5 CA-MRSA, PVL-pos;
1/5 CA-MSSA, PVL-pos
NR
Yu¨ksel et al., 2004 [31] Case report 1 3 y M OM of the ﬁbula Doppler US Staphylococcus aureus Pleural and pulmonary
involvement
Newgard et al., 2002 [23] Case report 1 12 y M OM of the sacroileum, humerus MRI Staphylococcus aureus Pulmonary involvement
Walsh and
Phillips 2002 [30]
Case report 4 4 y; 2.5 y;
11 y; 6 y
3/4 F;
1/4 M
1/4 OM of the femur; 1/4 OM of the ileum;
1/4 OM of the ﬁbula; 1/4 pyomyositis of
the soleus muscle
1/4 CT; 2/4 MRI;
1/4 Doppler US
3/4 Staphylococcus aureus;
1/4 Streptococcus pyogenes
3/4 Pulmonary involvement;
1/3 septic shock and
disseminated intravascular
coagulation and death due
to multiple organ failure
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Table 1 (Continued )
First author, publication
year [Ref.]
Study design Number of
patients
Age Sex MSI type and location Method of DVT diagnosis Causative pathogen Non-orthopedic
complications
Gorenstein
et al., 2000 [13]
Case report 3 11 y; 10 y;
10 y
3/3 M 3/3 OM of the femur 2/3 Doppler US;
1/3 venogram
3/3 Staphylococcus aureus 3/3 Pulmonary involvement;
1/3 death due to multiple
organ failure
Letts et al., 1999 [20] Case report 1h 11.5 y M OM and septic arthritis of the sacroileum Doppler US,
echocardiogram
Staphylococcus aureus Pulmonary involvement,
endocarditis
Smith et al., 1997 [27] Case report 2 4 y; 35 m 2/2 F 1/2 OM of the femur; 1/2 OM of the ileum 2/2 CT 2/2 Staphylococcus aureus 2/2 Pulmonary involvement;
1/2 septic shock and
disseminated intravascular
coagulation and death due
to multiple organ failure
Jupiter et al., 1982 [16] Case report 2 12 y; 12 y 1/2 M;
1/2 F
1/2 OM of the humerus;
1/2 OM of the femur, tibia
2/2 Venogram 2/2 Staphylococcus aureus 2/2 Pulmonary involvement
Horvath et al. 1971 [15] Case report 1 9 y M OM of the tibia Venogram Staphylococcus aureus Pulmonary involvement
CT, computed tomography; DVT, deep venous thrombosis; F, female; ICU, intensive care unit; m, month(s); M, male; MRI, magnetic resonance imaging; MRSA, methicillin-resistant Staphylococcus aureus (CA-MRSA, community-
acquiredMRSA); MSI, musculoskeletal infection; MSSA, methicillin-susceptible Staphylococcus aureus (CA-MSSA, community-acquired MSSA); NR, not reported; OM, osteomyelitis; pos, positive; PVL, Panton–Valentine leukocidin;
US, ultrasonography; y, year(s).
a Mean.
b This patient had a factor V G1691A heterozygous mutation, a hereditary protein C deﬁciency, an elevated level of factor VIII, and hyperlipidemia.
c One patient with DVT and septic arthritis, and one patient with DVT and pyomyositis were excluded. One patient had a prothrombin 20210A heterozygous mutation, and another patient had a factor V Leiden heterozygous
mutation.
d One patient had a factor V Leiden heterozygous mutation, three patients had transient elevation of antiphospholipid antibodies, and two patients had transient elevation of factor VIII.
e One patient was retrospectively included.
f Three patients had a transient elevation of lupus anticoagulant, one patient had positive anticardiolipin antibody, seven patients had elevated ﬁbrinogen levels, and three patients had transient decreases of protein C and protein
S levels.
g Two patients had a transient decrease of protein C levels.
h This patient had a hereditary protein C deﬁciency.
Table 2
Comparative data extracted from the included studies regarding patients with musculoskeletal infections with and without deep venous thrombosis
First author,
publication year [Ref.]
Number of male
patients, n/N (%)
Age, mean (range) CRP value at
admission
ESR value at admission MRSA infection, n/N (%) MSSA infection,
n/N (%)
Mean length of
hospital stay
DVT-pos vs. DVT-neg DVT-pos vs. DVT-neg DVT-pos vs. DVT-neg DVT-pos vs. DVT-neg DVT-pos vs. DVT-neg DVT-pos vs. DVT-neg DVT-pos vs. DVT-neg
Bouchoucha
et al., 2010 [4]
NRa 8.1 years (23 months–13.5 years) vs.
7.7 years (7 months–13.5 years);
p=NS
Mean mg/l: 251 vs.
109; p=0.001
Mean 1st h (NR): 84 vs.
48; p=0.003
3/7 (43%) vs.
3/63 (5%); p=0.04
4/7 (57%) vs.
29/63 (46%); p=NS
NR
Hollmig
et al., 2007 [14]
8/11 (73%) vs.
122/201 (61%); p=0.6b
10.9 years (3–14 years) vs.
7.4 years (6 months–17.9 years);
p=0.07
Mean mg/dl: 169 vs.
68; p=NA
Mean mm/h: 62.5 vs.
54.9; p=NA
8/11 (73%) vs.
49/201 (24%); p=0.002
3/11 (27%) vs.
44/201 (22%); p=0.1
30.6 days vs.
9.5 days; p=NA
Crary
et al., 2006 [8]
7/10 (70%) vs.
15/25 (60%); p=0.9c
10.8 years (3–14 years) vs.
8 years (NR); p=0.14
Mean mg/dl: 22.6 vs.
15.2; p=0.06
Mean mm/h: 105 vs.
91; p=0.19
7/10 (70%) vs.
9/25 (45%); p=0.14
2/10 (20%) vs.
9/25 (45%); p=0.61
33.5 days vs.
14.2 days; p=0.001
CRP, C-reactive protein; DVT, deep venous thrombosis; ESR, erythrocyte sedimentation rate; MRSA,methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; NA, not applicable; neg, negative;
NR, not reported; NS, non-signiﬁcant; pos, positive.
a The sex ratio in case of associated DVT was tilted towards boys (6:1), but did not signiﬁcantly differ from that in the other cases of acute hematogenous osteomyelitis.
b Calculated data, Yates corrected chi square.
c Calculated data, Fisher exact.
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three comparative studies. Speciﬁcally, the observed respective
differences were non-signiﬁcant. Finally, pulmonary involvement
due to septic emboli was frequently observed (65% of the evaluated
children).
Concerning the increased number of boys encountered among
the evaluated patients with MSIs who developed DVT, it is well-
known that thromboses are more common in females in all age
groups except infants.32 However, osteomyelitis-induced DVT
appears to be more common in males, because boys are 1.2–3.7-
times more likely than girls to contract osteomyelitis.33,34 Our
ﬁndings are in accordance with this observation. Also, boys
compared to girls are more prone to skeletal injuries that
predispose to infection. Speciﬁcally, 15 of the 93 children
evaluated were reported to have a history of preceding trauma.
Among the 13 children with available data on sex and with a
history of preceding trauma, nine (69%) were boys.
In our study, S. aureus was identiﬁed as the predominant
pathogen responsible for MSI-associated DVT. This was expected,
since S. aureus is the main pathogen in microbiologically-
conﬁrmed cases of osteomyelitis and is responsible for 89% of
osteomyelitis cases in immunocompetent children.35 With regard
to complications, metastatic pulmonary involvement has become
more common in patients with invasive community-acquired S.
aureus disease nowadays. Speciﬁcally, investigators at the Baylor
College of Medicine reported that among 70 patients with CA-
MRSA infections, 47 had abnormal pulmonary imaging ﬁndings
compared to only 12 of 43 with CA-MSSA infections (p < 0.001).
Among the 47 patients with CA-MRSA in that series, 21 had MSIs
(20 cases of osteomyelitis, one of septic arthritis).11
Based on the evaluation of the ﬁndings of three comparative
studies, we found that MRSA infections were encountered
signiﬁcantly more frequently among patients with DVT compared
to those who did not develop DVT. Notably, this was not the case
for MSSA. Many factors may possibly account for this observation.
First, MRSA infections are considered to be more severe and
associated with vascular complications compared to MSSA
infections. The increased severity of MRSA MSIs was also suggested
by the signiﬁcantly higher inﬂammatory markers on admission
that was found in the study of Bouchoucha et al.4 Moreover, the
increased severity of MRSA infections may also result in increased
length of hospital stay, which may potentially predispose to DVT.
However, other non-infectious factors may also account for the
increased length of hospital stay in children who developed DVT
compared to those who did not. As the clinical presentation of
osteomyelitis and DVT can be very similar, their combination may
exist with greater frequency than clinically appreciated. Moreover,
as suggested by our ﬁndings as well, vascular complications
nowadays appear to be more common in infections due to CA-
MRSA than in the past.
The annual incidence of VTE in children has been estimated at
0.7–1 per 100 000 population with a prevalence of 5.3 per 10 000
hospital admissions according to the Canadian VTE registry.36 Stein
et al. recorded the number of infants and children discharged from
hospitals in the USA with a diagnostic code of pulmonary
embolism and DVT. The rate of pulmonary embolism was 0.9/
100 000 children/year and of DVT 4.2/100 000 children/year, with
the rates being higher in infants than in children aged 2–14 years.32
Hence, although DVT is a relatively rare event in childhood, it
should be considered in children with relevant clinical ﬁndings,
especially in the face of congenital thrombophilic disorders.
Interestingly, the majority of children with MSIs, associated with
DVT, and included in this review were not tested for congenital
thrombophilic disorders, likely due to the fact that thrombophilia
is a relatively new medical ﬁeld, and many physicians dealing with
MSIs may not be so familiar with it.Infections have been underappreciated as a predisposing factor
for DVT in children. In the ﬁrst reported analysis of DVT in
childhood, infections were the underlying predisposing factor in
7.3% of the cases.36 In the Canadian childhood thrombophilia
registry, infection/sepsis was the ﬁfth most common predisposing
factor for DVT/pulmonary embolism with 12%, following central
venous catheters (CVCs) (60%), malignancy (25%), cardiac surgery
(19%), and other major surgery (15%).37 In a prospective Dutch
study of VTE in childhood, infection was by far the most prevalent
risk factor (46%).38 Although none of these studies provide details
regarding the site and/or type of DVT-promoting infections,36–38 it
is well-known that even common infections such as urinary tract
and respiratory tract infections are associated with an increased
risk of VTE in adults.39–41 Although similar epidemiological studies
linking common infections with VTE do not exist in children, it is
likely that pediatric infections create a pro-coagulant environ-
ment. In this regard, MSIs are considered unique due to the fact
that prolonged bed rest and immobilization of the extremities are
frequent consequences that are not usually seen with other types
of infection.
Our study suggests that MRSA infections, contrary to MSSA
infections, are encountered signiﬁcantly more frequently among
patients with DVT compared to those without DVT. Although the
reasons for the higher frequency of DVT in association with MRSA
infections are not well-known, Martinez-Aguilar et al. suggested
that leukocidin, a multi-component protein-toxin and the product
of the pvl gene, may be the responsible toxin associated with DVT
in children with MSIs due to S. aureus.21 Moreover, many strains of
S. aureus release various exotoxins. Among them, a-toxins act on
cell membranes and produce aggregation of platelets and smooth
muscle spasm, both of which predispose to thrombosis, while the
enzyme coagulase interacts with ﬁbrinogen and causes plasma
clotting. Furthermore, inﬂammation induces inhibition of ﬁbrino-
lysis by elevated levels of plasminogen activator inhibitor 1, while
via inﬂammatory mediators, like interleukin 6 (IL-6), it increases
the number of newly formed and thrombogenic platelets.2 In
bloodborne infections, bacterial adhesion to thrombogenic sur-
faces plays an important pathogenic role. Binding of S. aureus to
platelets on damaged endocardium is believed to be the ﬁrst step
in the development of infective endocarditis. Studies with in vitro
experimental systems show that S. aureus clumping factor A and
ﬁbronectin-binding protein A stimulate rapid platelet aggrega-
tion.42–44
Even though the operational mechanisms involved in the
pathogenesis of MSI-related DVT due to S. aureus have not been
studied, the available published evidence, though scarce, suggests
that they are likely similar to those of infectious endocarditis and
explain the development of thrombi within the venous vasculature
adjacent to the infected musculoskeletal site. Very recent
observations also indicate that neutrophil extracellular traps
(NETs), a previously unrecognized link between inﬂammation
and thrombosis, may play a role.45 More speciﬁcally, NETs are a
meshwork of DNA ﬁbers comprising histones and antimicrobial
proteins. They provide a scaffold and stimulus for thrombus
formation, and in vitro experiments have shown that NETs
perfused with blood promote platelet adhesion, activation, and
aggregation.
Several limitations should be taken into consideration when
interpreting the results of this review. First, the majority of the
included studies were case reports. Since case reports are prone to
publication bias, this should be taken into consideration when
interpreting the ﬁndings of this review. Second, the remaining
included case series/cohort studies had a retrospective study
design. Both the above-mentioned factors hamper the establish-
ment of ﬁrm conclusions regarding the pre-deﬁned goals of our
review, i.e., the frequency of DVT among patients with MSIs, the
E. Mantadakis et al. / International Journal of Infectious Diseases 16 (2012) e236–e243e242frequency of non-orthopedic complications due to dissemination
of the skeletal infections (particularly to the lungs), the prevalence
of MRSA vs. MSSA in cases of MSIs complicated by DVT, and ﬁnally
the differences, if any, in laboratory and clinical parameters of
MRSA vs. MSSA MSIs. A prospective study is needed in order to
further clarify the above-mentioned issues. Moreover, a consider-
able number of the evaluated studies did not specify whether the
evaluated children had a CVC or not. Iatrogenic DVT caused by
CVCs represents a different issue not associated with MSI.
However, in our experience most children with MSIs are less
likely to carry a CVC, and more likely to have a peripheral venous
catheter for antibiotic therapy. Furthermore, a considerable
number of the evaluated studies did not provide clear statements
with regard to whether the site of thrombosis was adjacent to the
site of the MSI or not.
Third, in almost all studies, no data were provided regarding
DVT treatment and its duration. Also, the location of the thrombus
was not clearly described within the involved extremity or
elsewhere. Furthermore, the presence of CVCs or other risk factors
was not analyzed. Moreover, the type of pulmonary involvement
was not speciﬁed in detail (pneumonia, septic emboli, pleuritis, or
a combination of these). Only a prospective and active search for
DVT in all patients with MSIs may sufﬁciently and deﬁnitely
answer these important questions. To this end, diagnostic imaging
studies should not be limited to patients with notable edema of the
involved extremity, because such patients may not have DVT,
while others without appreciable edema may have radiographi-
cally documented DVT. Fourth, this systematic review cannot
answer the question of the extent to which congenital or acquired
(e.g., lupus anticoagulants) thrombophilic disorders predispose
children with established MSIs to DVT. Fifth, it should be noted that
eight common children were described in the studies by Hollmig
et al. and Crary et al.46 However, since only descriptive statistics,
contrary to summary statistics, were implemented in our review,
we believe that the inclusion of both studies does not inﬂuence our
ﬁndings. Finally, the methods of DVT diagnosis were inconsistent
among the various included studies, casting some doubts about the
actual presence of this vascular complication.
In conclusion, despite the unavoidable methodological limita-
tions induced by the inclusion of a considerable number of case
reports and retrospective studies, our ﬁndings suggest that boys
seem to be more frequently affected than girls by MSIs complicated
by DVT. In addition, S. aureus is the main responsible pathogen,
while pulmonary involvement by septic emboli seems to be a
frequent complication. Moreover, MRSA appears to be more
commonly associated with DVT compared to MSSA. However,
prospective studies are needed in order to shed light on the above-
mentioned clinical considerations. Better knowledge of this
vascular complication and appropriate imaging studies of patients
with MSIs directed at prompt and accurate diagnosis, along with
the institution of appropriate preventative and therapeutic
measures, will minimize the risk of dissemination to the lungs
and the associated consequences.
Conﬂict of interest: No conﬂict of interest to declare.
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